Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asuka Katsuki

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 23, 2013
[Depressive state in elderly people]Asuka Katsuki, Hikaru Hori, Jun Nakamura
CNS Spectrums|September 5, 2020
Effects of the number of hospitalizations on cognitive function in Japanese patients with stable schizophreniaHikaru Hori, Kiyokazu Atake, Asuka Katsuki, et al.
Frontiers in Psychiatry|March 24, 2018
Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot StudyHikaru Hori, Asuka Katsuki, Kiyokazu Atake, et al.
International Clinical Psychopharmacology|November 20, 2019
Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute schizophreniaHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Journal of Clinical Psychopharmacology|January 5, 2013
Herbal medicine (Shakuyaku-kanzo-to) improves olanzapine-associated hyperprolactinemia: a case reportHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Journal of UOEH|September 16, 2016
Marked Improvement of Meige Syndrome in a Japanese Male Patient with Schizophrenia After Switching from Risperidone to Paliperidone: A Case ReportReiji Yoshimura, Hikaru Hori, Asuka Katsuki, et al.
Psychiatry Research|June 17, 2020
Predictors of return to work success among Japanese employees with major depressive disorderKiyokazu Atake, Hikaru Hori, Asuka Katsuki, et al.
Neuropsychiatric Disease and Treatment|April 22, 2015
Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorderKiyokazu Atake, Reiji Yoshimura, Hikaru Hori, et al.
Annals of General Psychiatry|January 16, 2016
Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophreniaReiji Yoshimura, Hikaru Hori, Asuka Katsuki, et al.
Neuropsychiatric Disease and Treatment|September 14, 2016
Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case reportRyohei Igata, Hikaru Hori, Kiyokazu Atake, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 23, 2013
[Depressive state in elderly people]Asuka Katsuki, Hikaru Hori, Jun Nakamura
CNS Spectrums|September 5, 2020
Effects of the number of hospitalizations on cognitive function in Japanese patients with stable schizophreniaHikaru Hori, Kiyokazu Atake, Asuka Katsuki, et al.
Frontiers in Psychiatry|March 24, 2018
Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot StudyHikaru Hori, Asuka Katsuki, Kiyokazu Atake, et al.
International Clinical Psychopharmacology|November 20, 2019
Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute schizophreniaHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Journal of Clinical Psychopharmacology|January 5, 2013
Herbal medicine (Shakuyaku-kanzo-to) improves olanzapine-associated hyperprolactinemia: a case reportHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Journal of UOEH|September 16, 2016
Marked Improvement of Meige Syndrome in a Japanese Male Patient with Schizophrenia After Switching from Risperidone to Paliperidone: A Case ReportReiji Yoshimura, Hikaru Hori, Asuka Katsuki, et al.
Psychiatry Research|June 17, 2020
Predictors of return to work success among Japanese employees with major depressive disorderKiyokazu Atake, Hikaru Hori, Asuka Katsuki, et al.
Neuropsychiatric Disease and Treatment|April 22, 2015
Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorderKiyokazu Atake, Reiji Yoshimura, Hikaru Hori, et al.
Annals of General Psychiatry|January 16, 2016
Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophreniaReiji Yoshimura, Hikaru Hori, Asuka Katsuki, et al.
Neuropsychiatric Disease and Treatment|September 14, 2016
Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case reportRyohei Igata, Hikaru Hori, Kiyokazu Atake, et al.
Pageof 9